We are proud to have advised Lead Ventures as the lead investor in XUND’s EUR 6 million Pre-Series A financing round. With additional support from J&T Ventures, MassMutual Ventures, tba network and LANA Ventures, this funding will fuel XUND’s expansion across the DACH region and the UK.

By leveraging AI powered medical software, XUND is revolutionizing the patient journey—turning data into actionable health insights.

The transaction team was led by Wolfgang Schwackhöfer and Alexander Lotz (Venture Capital) and Sonja Hebenstreit (IP).